V-Wave scores $28 mln Series B
Israel-based V-Wave Ltd, which is developing a implantable, interatrial shunt that treats heart failure, has closed $28 million in Series B funding. The investors included Johnson & Johnson Innovation - JJDC Inc, TriVentures, Pura Vida Investments, BioStar Ventures, BRM Group, Pontifax and Edwards Lifesciences.
11 January 2016•3 mins read
